NCT07900945
Study of Single and Multiple Ascending Doses of CM551 in Healthy Participants
StatusNot Yet Recruiting
PhasePhase 1
SponsorKeymed Biosciences Co.Ltd
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Incidence of Treatment-Emergent Adverse Events
Timeframe: through study completion, an average of 1.5 years
Arms and interventions
SAD Cohorts 1~4 Experimental ArmExperimental
SAD Cohorts 1~4 Placebo ArmPlacebo comparator
MAD Cohorts 5~6 Experimental ArmExperimental
MAD Cohorts 5~6 Placebo ArmPlacebo comparator
Biologicals: CM551
Drugs: Placebo
Sites
1 site in 1 country
- Tianjin Medical University General HospitalTianjin, Tianjin Municipality, China